16-50712635-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001370466.1(NOD2):​c.2381+262C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.602 in 551,014 control chromosomes in the GnomAD database, including 105,205 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 28758 hom., cov: 32)
Exomes 𝑓: 0.60 ( 76447 hom. )

Consequence

NOD2
NM_001370466.1 intron

Scores

2
Splicing: ADA: 0.00004300
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.223
Variant links:
Genes affected
NOD2 (HGNC:5331): (nucleotide binding oligomerization domain containing 2) This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-50712635-C-G is Benign according to our data. Variant chr16-50712635-C-G is described in ClinVar as [Benign]. Clinvar id is 1237708.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.665 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NOD2NM_001370466.1 linkuse as main transcriptc.2381+262C>G intron_variant ENST00000647318.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NOD2ENST00000647318.2 linkuse as main transcriptc.2381+262C>G intron_variant NM_001370466.1 P1Q9HC29-2

Frequencies

GnomAD3 genomes
AF:
0.605
AC:
91968
AN:
151922
Hom.:
28745
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.586
Gnomad AMI
AF:
0.745
Gnomad AMR
AF:
0.564
Gnomad ASJ
AF:
0.775
Gnomad EAS
AF:
0.193
Gnomad SAS
AF:
0.347
Gnomad FIN
AF:
0.569
Gnomad MID
AF:
0.658
Gnomad NFE
AF:
0.670
Gnomad OTH
AF:
0.623
GnomAD4 exome
AF:
0.600
AC:
239544
AN:
398974
Hom.:
76447
Cov.:
3
AF XY:
0.589
AC XY:
123154
AN XY:
208990
show subpopulations
Gnomad4 AFR exome
AF:
0.596
Gnomad4 AMR exome
AF:
0.504
Gnomad4 ASJ exome
AF:
0.786
Gnomad4 EAS exome
AF:
0.226
Gnomad4 SAS exome
AF:
0.395
Gnomad4 FIN exome
AF:
0.577
Gnomad4 NFE exome
AF:
0.677
Gnomad4 OTH exome
AF:
0.613
GnomAD4 genome
AF:
0.605
AC:
92025
AN:
152040
Hom.:
28758
Cov.:
32
AF XY:
0.596
AC XY:
44259
AN XY:
74312
show subpopulations
Gnomad4 AFR
AF:
0.586
Gnomad4 AMR
AF:
0.564
Gnomad4 ASJ
AF:
0.775
Gnomad4 EAS
AF:
0.193
Gnomad4 SAS
AF:
0.348
Gnomad4 FIN
AF:
0.569
Gnomad4 NFE
AF:
0.670
Gnomad4 OTH
AF:
0.619
Alfa
AF:
0.509
Hom.:
1429
Bravo
AF:
0.605
Asia WGS
AF:
0.294
AC:
1028
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 10, 2018- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 82% of patients studied by a panel of primary immunodeficiencies. Number of patients: 78. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
5.1
DANN
Benign
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000043
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4785225; hg19: chr16-50746546; API